JUBLPHARMA.BOJUBLPHARMA.BOBSE
Loading
Year-over-year earnings per share growth rate
Percentile
P23
Within normal range
vs 2Y Ago
-7.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -53.49% |
| Q3 2025 | 16.95% |
| Q2 2025 | -33.16% |
| Q1 2025 | 52.43% |
| Q4 2024 | -1.55% |
| Q3 2024 | -78.75% |
| Q2 2024 | 924.93% |
| Q1 2024 | -187.44% |
| Q4 2023 | 7.11% |
| Q3 2023 | 885.00% |
| Q2 2023 | 106.50% |
| Q1 2023 | -527.55% |
| Q4 2022 | -388.24% |
| Q3 2022 | -88.51% |
| Q2 2022 | -20.86% |
| Q1 2022 | 16.88% |
| Q4 2021 | -64.33% |
| Q3 2021 | -11.10% |
| Q2 2021 | -7.09% |
| Q1 2021 | -21.02% |
| Q4 2020 | -2.20% |
| Q3 2020 | 154.25% |
| Q2 2020 | 156.02% |
| Q1 2020 | -83.09% |
| Q4 2019 | -18.45% |
| Q3 2019 | 34.88% |
| Q2 2019 | 281.97% |
| Q1 2019 | -138.11% |
| Q4 2018 | 24.00% |
| Q3 2018 | 3.85% |
| Q2 2018 | 30.78% |
| Q1 2018 | -27.13% |
| Q4 2017 | 65.74% |
| Q3 2017 | -12.82% |
| Q2 2017 | -1.56% |
| Q1 2017 | 24.71% |
| Q4 2016 | -17.31% |
| Q3 2016 | -8.37% |
| Q2 2016 | 420.51% |
| Q1 2016 | -73.43% |